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ABSTRACT 
 
Using flow cytometry measurements combined with quantitative analysis of cell-cycle 
kinetics, we show that rhesus monkey ES cells are characterised by an extremely rapid transit 
through the G1 phase which accounts for 15% of the total cell-cycle duration. Monkey ES 
cells exhibit a non phasic expression of cyclin E which is detected during all phases of the 
cell-cycle and do not growth-arrest in G1 following γ-irradiation, reflecting the absence of a 
G1 checkpoint. Serum deprivation or pharmacological inhibition of Mitogen Activated 
Protein Kinase Kinase (MEK) did not result in any alteration in the cell-cycle distribution, 
indicating that ES cell growth does not rely on mitogenic signals transduced by the 
Ras/Raf/MEK pathway. Taken together, these data indicate that rhesus monkey ES cells, like 
their murine counterparts, exhibit unusual cell-cycle features in which cell-cycle control 
mechanisms operating during the G1 phase are reduced or absent. 
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INTRODUCTION 
 
There is accumulating evidence that cell-cycle control in mouse embryonic stem (ES) and 
somatic cells differs in that the mouse ES cell-cycle is not dependent on a functional 
p16ink4a/cyclin D:Cyclin-dependent kinase (Cdk)4/pRB:E2F pathway [1-5]. Rather, the cyclin 
E:Cdk2 and cyclin A:Cdk2 complexes in ES cells are constitutively active throughout the 
cell-cycle suggesting that the mitotic cycle is constitutively primed for DNA replication [6]. 
Interestingly, mouse ES cells have a very short G1 phase of approximately 1.5 hr and they 
predominantly express the hyperphosphorylated form of the retinoblastoma protein (pRB) 
(specific of the S and G2/M phases of the cell-cycle) [7], indicating that newly formed cells 
can enter a new phase of DNA replication very shortly after exit from mitosis. Another 
striking feature of the mitotic cycle of mouse ES cells is the lack of dependency on serum 
stimulation [8] and Mitogen Activated Protein Kinase Kinase (MEK)-associated signalling 
[4,9,10]. Mouse ES cells rely on Phosphatidyl Inositol-3 kinase (PI3K)-dependent signalling 
for progression through the G1 phase [10] as well as for inhibition of differentiation [11]. 
However, PI3K activity is not dependent on persistent serum stimulation [10], but rather 
largely relies both on stimulation of the Leukemia Inhibitory Factor (LIF) receptor and on 
expression of the ES cell-specific Eras factor [12]. In addition, mouse ES cells do not undergo 
cell-cycle arrest at the G1 checkpoint in response to DNA damage or nucleotide depletion 
[13,14], although they synthetize abundant quantities of transcriptionally active p53 [13]. 
Taken together, these findings indicate that the mitotic cycle of ES cells largely escapes from 
external mitogenic stimuli and instead relies largely on intrinsic factors. 
A crucial question is whether the unusual cell-cycle characteristics of mouse ES cells 
are shared by primate ES cells. Here, we show that rhesus monkey ES cells display most of 
the cell-cycle characteristics of mouse ES cells, including shortening of G1 phase, non-phasic 
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expression of cyclin E, predominance of hyperphosphorylated RB, lack of dependency on 
serum stimulation and MEK signalling, and absence of a DNA damage checkpoint in G1. We 
thus propose that these unique cell-cycle characteristics are critical, and possibly universal 
features of ES cells. 
 
MATERIAL AND METHODS 
  
Rhesus monkey ES cell culture. 
Procedures for rhesus ES cell line ORMES-1 and ORMES-6 culture have been described 
previously [15]. Briefly, ORMES ES cells were grown at 37°C in 5% CO2 atmosphere on 
mitotically inactivated mouse embryonic fibroblasts (MEF) feeder cells in Dulbecco’s 
Modified Eagle’s Medium (DMEM) (Invitrogen) supplemented with 20% foetal bovine 
serum (FBS) (Hyclone), 0.1 mM ß-mercaptoethanol (Sigma), 1% nonessential amino acids 
(Invitrogen), and 2 mM L-glutamine (Invitrogen). ES cell colonies were passaged every 4-5 
days by treatment with 1 mg/ml collagenase IV (20-30 mins at 37°C), followed by 
mechanical dissociation. 
PD98059 and U0126 (Sigma) were dissolved in dimethylsulfoxide (Sigma) and added 
to the medium at a concentration of 25 µM and 10 µM, respectively. 
 
Lentiviral vector production and infection of ES cells. 
R4SA-EFs-EGFP-W, a Simian Immunodeficiency Virus-based vector, harbors the sequence 
encoding the enhanced Green Fluorescent Protein (eGFP) driven by the minimal version of 
the human EF1α promoter (EFs). It was generated by replacing the ClaI/XhoI restriction 
fragment containing the CMV-GFP cassette in pSIV-gaMES4 [16] by a ClaI/SalI restriction 
fragment containing the EFs-EGFP cassette (a gift from Patrick Salmon). The method for 
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producing SIV-based vectors in 293T cells is fully described elsewhere [17,18]. Briefly, 293T 
cells were transfected with a mixture of DNAs containing 10 µg of the pGRev plasmid 
encoding the VSV-G envelope, 10 µg of pSIV3+ plasmid encoding the gag, pol, tat and rev 
proteins, and 13 µg of the R4SA-EFs-EGFP-W plasmid, using the calcium phosphate 
precipitation technique. The following day, cells were refed with 7 ml of DMEM and further 
cultured for 24 hours. The supernatant was then collected, cleared by centrifugation (3,000 
RPM, 15 min) and passed through a 0.8 µM filter. Prior to infection, ORMES-1 cells were 
treated with 1mg/ml collagenase IV for 3-5 min at 37°C. Clumps of undifferentiated ORMES-
1 cells were isolated by mechanical dissociation and transferred to fresh medium (500 µl) 
containing SIV-eGFP. Cells were incubated for 4 hrs at 37°C, before being replated on fresh 
feeder cells.  
 
Time-Lapse Videomicroscopy recording of cell division. 
ORMES-1 cells were grown in a 5% CO2 atmosphere at 37°C for 4-5 days in a Pecon 
incubating chamber placed on a Leica DMIRBE inverted microscope stage. Observations of 
individual eGFP+ cells were made with an 10x objective under halogen illumination. Twenty 
fields were scanned per coverslip per hour using Metamorph software. Subsequent analysis of 
the movies allowed estimation of the cell-cycle length of individual eGFP+ cells as measured 
by the time elapsed between two successive mitosis [19]. 
 
Cell-cycle kinetics measurements. 
S phase and G1+G2+M phase durations can be derived from Bromodeoxyuridine (BrdUrd) 
cumulative labeling experiments [20-22]. Cumulative BrdUrd labeling was performed on 
ORMES  cells grown on coverslips in 24-well plates in standard conditions. Forty-eight hrs 
after plating, BrdUdR (20 µg/ml) was added to the medium for the indicated times. Cells were 
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fixed with 2% paraformaldehyde (PFA) and the labeling index (LI) values determined 
(proportion of BrdUrd+ cells, i.e. cells that were in S phase during BrdUrd exposure, with 
respect to the undifferentiated pool, i.e. the Oct-4+ cell population). Percentage of labelled 
mitosis (PLM) labeling [21-23] was used to determine the G2/M duration. Forty-eight hrs 
after plating, cultures were pulse-labelled for 1 hr with BrdUrd (20 µg/ml). For both 
procedures, three independent experiments were performed with the ORMES-1 cell line and 
two experiments with ORMES-6. Each time point was repeated on two sister coverlips. After 
survival periods, cultures were fixed in 2% PFA and processed for the detection of BrdUrd 
incorporation and Oct-4 expression. Cells were counterstained with Hoechst 33258 for 3 min 
to allow the identification of mitotic figures. 
 
In situ immunofluorescence. 
ORMES cells were fixed in 2% PFA in phosphate-buffered saline (PBS) at 4°C for 1 hr. 
Immunohistochemistry was performed by a two-step procedure. Cells were permeabilized in 
Tris Buffer Saline (TBS) + 0.2% Triton X-100, 0.1% Tween-20, for 20 min. Non-specific 
binding was blocked with 10% normal goat serum (Jackson ImmunoResearch Laboratories) 
for 1 hr at RT. To detect Oct-4 protein, cells were first incubated for 1 hr at 30°C with mouse 
monoclonal antibody anti-Oct-4 (C-10: sc5279) from Santa-Cruz biotechnology (1:1000 in 
DAKO-diluent). Cyclin E and Cyclin A were detected using C-19 (sc-198) and H-432 (sc-
751) respectively antibodies (1/100, Santa Cruz Biotechnology) incubated overnight at 4°C. 
Ki-67 was detected using phycoerythrine-conjugated anti-human Ki-67 monoclonal antibody 
(BD Bioscience, ref. 36525). After three rinses in TBS, cells were exposed either to affinity-
purified goat anti-mouse or goat anti-rabbit IgG conjugated either to indocarbocyanine or to 
cyanin (respectively Cy3 and Cy2, Jackson ImmunoResearch Laboratories) for 1 hr at RT 
followed by nuclear staining with 1ng/ml Hoechst 33258 for 3 min. After three rinses in TBS, 
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coverslips were mounted on slides. To detect both Oct-4 expression and BrdU incorporation, 
cells were first treated to reveal Oct-4 expression as described above. DNA was then 
denatured by incubation in 2N HCl, followed by a wash in a borate buffer, pH 8.5. Non-
specific binding was blocked with 10% normal goat serum. BrdU incorporation was revealed 
by incubation with Alexa 488-conjugate anti-BrdU antibody (1:50 in DAKO-diluent) 
(Molecular Probes) for 2 hours at RT. Nuclei were counterstained with Hoechst 33258. 
Coverslips were examined using an oil objective microscope under UV light to detect FITC 
(filter 450-490 nm), indocarbocyanine 3 (filter 550-570 nm) and Hoechst 33258 (filter 355-
425 nm). Coverslips were scanned at regular spacing with a grid corresponding to a field of 
0.128 mm2. 100 to 150 fields were observed per coverslip. Immunopositive cells were plotted 
onto a chart using the Mercator software (Explora Nova). 
 
Flow cytometric analysis of cell cycle distribution. 
Single cell suspensions of ORMES cells were obtained by treatment with 1 mg/ml 
collagenase IV (37°C for 20-30 min) followed by treatment with 0.1% trypsine (37°C for 3 
min). For DNA content analysis, cells were fixed in 70% ethanol, rehydrated in PBS, treated 
for 30 min with RNase A (1 mg/ml) and for 5 min with propidium iodide (1µg/ml). 
Fluorescence intensity was determined by flow cytometry on a Becton Dickinson FACscan 
equiped with a 488 nm argon laser. Data acquisition was performed with the CellQuest 
(Becton Dickinson) software, and the percentages of G1-, S-, and G2-phase cells were 
calculated with the MODFIT-LT software program (Verity Sofware House Inc). To 
discriminate proliferating ORMES-1 cells from non-proliferating feeder cells, cultures were 
exposed to BrdUdR (20 µg/ml) for 24 hrs. Fresh medium containing BrdUdR was changed 
every 12 hrs. Colonies were then dispersed into a single cell suspension, fixed in 70% ethanol 
and rehydrated in PBS. DNA denaturation was subsequently performed by incubation in 2N 
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HCl followed by three washes in PBS containing 0.5% Tween and 0.5% BSA (PBT). Cells 
were then incubated with FITC-conjugated anti-BrdU monoclonal antibody (BD Bioscience, 
1:50 in PBT) for 30 min at RT in the dark. After extensive washes in PBT, cells were 
incubated with 1 mg/ml RNAse (20 min, RT) followed by propidium iodide treament (1 
µg/ml) and analysed as indicated above. 
 
Western blotting. 
Cells were lysed in 20 mM Hepes pH 7.4, 100 mM NaCl, 50 mM NaF, 1% Triton X-100, 
10% glycerol, 1 mM dithiothreitol, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl 
fluoride and a cocktail of protease inhibitors (Roche) for 1 hour at 4°C. Protein lysates were 
then cleared by centrifugation (14,000 RPM for 20 min). Total proteins (30 µg) were 
electrophoresed on 10% SDS-polyacrylamide gel and electroblotted onto nitrocellulose 
membranes. For analysis of pRB expression, 2 x 106 cells were lysed in 100 µl of 60 mM 
Tris-HCl pH 6.8, 1.25% SDS, 175 mM 2-Mercaptoethanol. Samples (30 µl) were analysed on 
5% SDS polyacrylamide gel. After overnight treatment with blocking buffer (50 mM Tris-Hcl 
pH 7.6, 150 mM NaCl, 5% dry milk), the membranes were probed with anti-cyclin E (Sigma 
C4976), anti-cyclin A (Santa Cruz sc-751), or anti-pRB monoclonal antibodies (BD 
Bioscience, ref. 554136). Blots were incubated with horseradish peroxidase-coupled anti-
mouse, or anti-rabbit IgG and developed using ECL reagents (Amersham). 
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RESULTS 
 
Population doubling time and cell-cycle duration of the ORMES-1 ES cells. 
ORMES-1 cells were grown on mitotically inactivated MEF feeder cells in the presence of 
20% FBS [15]. They were routinely seeded at a 0.3 x 105 cells/cm2 cell density. Daily counts 
of cell numbers showed an initial moderate increase for the first three days (average doubling 
time of approximately 70 hrs) (Figure 1A). Counts returned an average doubling time of 
approximately 25 hrs during day 4 and 5. A negative binomial regression test performed in 
the R statistical computing environment (R Development Core Team, 2004) [24] revealed that 
there is a statistical difference in the growth rate between the 0-3 days period  and the 4-5 
days period (p < 0.05 for both growth curves), as indicated by the abrupt change in the slope 
of the growth curves at day 3. At day 6 and 7, cells reached confluency and population growth 
slowed most likely as a consequence of cell death and higher rates of spontaneous 
differentiation. 
To determine whether the variations in growth rates were paralleled by changes in the 
expression of pluripotency markers, colonies were immunolabelled to detect expression of the 
Oct-4 transcription factor (Figure 1B, C). At day 1, 69 +/- 22% (n = 14) of cells within 
colonies expressed Oct-4. This percentage peaked at 99 +/- 1% (n = 10) at day 3, to decline to 
80 +/- 30% (n = 10) at day 6. Therefore, all subsequent experiments were carried out on 
ORMES cells between day 3 and 5 which corresponds to the optimal growth phase, when 
99% of cells express the pluripotency marker Oct-4. Within the ORMES colonies, 99 +/- 1% 
of Oct-4+ cells were cycling cells, as shown by double immunolabelling against Ki-67 and 
Oct-4 (Figure 1D). 
Doubling-time is a crude measure of  proliferation rates and is contaminated with cell 
death and spontaneous differentiation. In order to accurately measure the mitotic cycle 
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duration, we performed time-lapse videomicroscopy analysis on individual ORMES-1 cells.  
Cells were infected with SIV-eGFP -a SIV-based lentiviral vector expressing the Enhanced 
Green Fluorescent Protein (eGFP)- at a multiplicity of infection of 100 virus/cell so as to 
transduce the eGFP gene into approximately 2-3% of the cell population. Infected cells were 
propagated for one month and weekly checked for expression of eGFP by fluorescent 
microscopy. The fraction of eGFP-expressing cells did not vary with time indicating identical 
rates of growth for infected and non-infected cells (data not shown). 
Cells were grown on inactivated MEF. 4 days after replating, the proliferative 
behavior of individual eGFP+ cells cells was recorded by time-lapse videomicroscopy during 
a 48hrs period. The time between two successive mitosis was calculated for 32 individual 
cells. As shown in Figure 2, the cell-cycle duration of individual ORMES-1 ranges from 12 to 
21 hrs (median value is 15 hrs). 
 
ORMES-1 ES cell have an unusual cell cycle distribution. 
Next, we examined the distribution of ORMES-1 cells in cell-cycle phases using single colour 
flow cytometry analysis after DNA staining with propidium iodide (PI). Cells were harvested 
at day 4 of the culture, corresponding to the maximum growth rate (Figure 1A). To rule out a 
putative bias due to the presence of growth-inactivated MEF, cultures were first incubated for 
24 hours with 50 µM BrdUrd in order to label all proliferating cells. Subsequent analysis of 
DNA content stained with PI was restricted to the BrdUrd+ cells (Figure 3A,B). Under these 
conditions, the fractions of G1, S and G2/M phase cells were 16 +/- 3%, 56 +/- 3%, and 28 +/- 
5% respectively. ORMES-1 cells were induced to differentiate by withdrawal of MEF and 
culture on gelatine-coated dishes for 1 week. Under these conditions, the fractions of G1, S 
and G2/M phase cells were 45 +/- 2%, 29 +/- 6%, and 26 +/- 5% respectively (Figure 3C). 
Therefore, differentiation of ORMES-1 cells is accompanied by dramatic changes in the cell-
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cycle distribution, characterized by a large increase in the proportion of cells in G1 phase and 
a decrease in the proportion of cells in S phase. 
 
Duration of individual phases of the cell cycle of ORMES-1 and ORMES-6 cells. 
We investigated the duration of the individual phases of the cell cycle in undifferentiated, 
self-renewing ORMES-1 and ORMES-6 cells, by combining the BrdUrd cumulative labeling 
technique [19,20] with computation of the percentage of labeled mitosis (PLM) [22, 23]. 
BrdUrd cumulative labeling is based on continuous BrdUrd exposure that leads to the 
incorporation of BrdUrd by successive cohorts of cycling cells progressing through S phase. 
The proportion of cells labeled by the BrdUrd exposure (LI) is monitored at regular intervals 
throughout the duration of TC-TS. In this system, prolonged exposure to BrdUrd for periods 
equal to TC-TS returns LI values of 100% [21]. TG1+G2+M is determined by projecting the 
extrapolated 100% LI value onto the x-axis. Projection on the negative limb of the x-axis 
determinates TS. So as to monitor the cell-cycle of undifferentiated cells, and to exclude 
spontaneously differentiating cells from the calculation, the LI was computed within the Oct-
4+ cell population (LI was calculated as the proportion of Oct4+ that were labeled with 
BrdUrd). Three independent BrdUrd cumulative labelling experiments were performed on 
ORMES-1 cells (Figure 4A). Cumulative BrdUrd labeling returned TC values ranging from 16 
(bue curve) to 20 hrs (green curve). TS, and  TG1+G2+M values were comprised between 8 (blue 
curve) and 10 hrs (green curve). One experiment of cumulative BrdUrd labeling in ORMES-6 
cells (black curve) returned TC, TS, and TG1+G2+M values of 17, 7 and 10 hrs, respectively.  
So as to estimate the duration of G2/M, the PLM method was implemented on sister 
cultures of the four independent experiments. Following a 1 hr exposure to BrdUrd, the time 
interval required for 100% labeling of mitotic figures corresponds to the passage through G2 
and M (Figure 4B). So as to restrict the analysis to undifferentiated, self-renewing ORMES 
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cells, the percentage of BrdUrd labelled mitotic figures was calculated within the Oct-4+ 
population. In ORMES-1 cells, this analytical procedure returned maximum values for G2/M 
of 9 (blue curve) to 10 hrs (green curve). When T values are substracted from TG1+G2/M values 
of the same experiment, this indicates that TG1 is reduced, ranging from a few minutes (blue 
and green curves) to 1 hr (red curve). In ORMES-6 cells, the PLM method indicates that 
maximum value of TG2/M is 7 hrs, returning a TG1 of 3 hrs (Figure 4B). These results show that 
the relative duration of G1 phase with respect to TC is comprised between 10 and 20% in 
ORMES – as shown in the FACS profile (Figure 3B). 
 
DNA damage checkpoints in ORMES-1 cells. 
To determine whether ORMES-1 cells have intact cell-cycle response to DNA damage, we 
analysed the effects of γ−irradiation on the cell cycle. In somatic cells, DNA damage results 
in rapid decrease in the S-phase population, due to p53- and Cdc25A-dependent mechanisms 
that prevent G1 cells with DNA damage from entering S phase [25-27]. As shown in Figure 5, 
the G1-phase fraction in ES cells harvested 3 to 18 hours after exposure to 6 Grays (Gy) 
ionizing radiation decreased from 22 +/- 0.1% to 7 +/- 0.5%. In contrast, the G2-phase 
fraction increased from 36 +/- 1% to 70 +/- 2%. These results indicate that ORMES-1 ES 
cells do not have a functional DNA-damage-response pathway for growth-arrest in G1. By 
contrast, they exhibit growth-arrest in the G2 phase. Note that the fraction of cells in the G1 
phase in the non-irradiated cell population (22%) was larger than the fraction of G1 cells 
found in the ES cell population analyzed in Figure 3B (16%) The presence of feeder cells in 
the irradiation experiment largely accounts for this difference as the vast majority of feeder 
cells were in G1 (data not shown). 
 
 
H
AL author m
anuscript    inserm
-00132737, version 2
 13 
Elevated levels of cyclins A and E throughout the cell cycle in ORMES-1 cells. 
We investigated cyclin E and cyclin A expression by immunoblot analysis. Undifferentiated 
ORMES-1 cells expressed high levels of cyclin A and E and these levels decreased 
dramatically after differentiation induced by low density culture in feeder-free conditions for 
5 days (Figure 6A). To determine if cyclin E and cyclin A levels fluctuate during cell-cycle 
progression as observed in somatic cells or, alternatively, if their expression is not cell-cycle 
dependent like in mouse ES cells [6], cyclin E and cyclin A were analysed by in situ 
immunofluorescence in the ORMES-1 cell population. 97 +/- 2% and 78 +/- 4% of Oct4+ 
ORMES-1 cells expressed cyclin E and cyclin A, respectively (Figure 6B,C). By contrast, 
only a small fraction of differentiated Oct4- ORMES cells expressed cyclin E (6 +/- 5%) and 
cyclin A (22 +/- 5%) (Figure 6B,D). Together, these data show that cyclin E is expressed 
throughout the cell-cycle in ORMES-1 cells indicating that its expression is not cell-cycle 
dependent. By contrast, not all Oct4+ ORMES-1 cells expressed cyclin A, suggesting that 
cyclin A expression is down-regulated in a sub-fraction of undifferentiated ORMES-1 cells. 
 
Predominence of hyperphosphorylated pRB in ORMES-1 cells. 
In parallel, phosphorylation of the retinoblastoma gene product (pRB) was 
investigated by immunoblot analysis. Mostly hyperphosphorylated pRB – specific of the S, 
G2 and M phases of the cell-cycle - was detected in undifferentiated ORMES-1 cells,  
whereas hypophosphorylated, G1-specific, pRB was predominant in differentiated cells 
(Figure 6E). The predominance of hyperphosphorylated pRB in ORMES-1 cells reflects the 
cell-cycle distribution of undifferentiated cells in which S and G2/M phases represent 
approximately 85% of the total cell cycle. 
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Dependency on serum stimulation and MEK signaling for G1/S transition in ORMES-1 
cells. 
We next addressed the question of whether rhesus monkey ES cells were dependent on 
persistent serum stimulation for progression in the cell-cycle. Following serum deprivation for 
24 hrs - a duration sufficient for every cell of the population to pass at least once through any 
serum checkpoint - we failed to detect any alteration in the cell-cycle distribution of ORMES-
1 cells (X2 test, p > 0.5), as shown by flow cytometry analysis (Figure 7A). Pairwise 
comparisons between control and serum-deprived sister cultures did not reveal significant 
variations in the percentages of cells in G1 (p = 0.5), in S (p = 0.92), and in G2/M (p = 0.89) 
(Student T-test, 3 experiments) (Figure 7B). 
Treatment of ORMES-1 cells for 24 hrs with 25 µM PD98059, or with 10 µM U0126, 
to specifically inhibit MEK activity [28,29] did not result in any significant alteration in the 
cell-cycle distribution (PD09805-treated versus control cells : X2 test, p > 0.5; U0126-treated 
versus control cells : X2 test, p > 0.5) (Figure 7C). Pairwise comparisons between control and 
PD98059-treated sister cultures did not reveal significant variations in the percentages of cells 
in G1 (p = 0.3), in S (p = 0.4), and in G2/M (p = 0.6) (Student T-test, 3 experiments). Pairwise 
comparisons between control and U0126-treated sister cultures did not reveal significant 
variations in the percentages of cells in G1 (p = 0.35), in S (p = 0.56), and in G2/M (p = 0.71) 
(Student T-test, 3 experiments) (Figure 7D). 
To confirm that MEK inhibition did not result in long term alteration of the growth 
rate, ORMES-1 cells were propagated in the presence of PD98059, or with vehicle alone, for 
7 days. Daily counts of cell numbers did not reveal difference in growth rates between PD-
treated and control cells (Figure 7E). Taken together these data indicate that ORMES-1 cells 
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do not require persistent mitogenic stimulation and functional MEK signaling to progress 
through the G1/S transition. 
 
DISCUSSION 
 
These results indicate that there are important similarities between murine and primate ES 
cell-cycle characteristics. Like their murine counterpart, rhesus monkey ES cells show a 
reduced G1 phase, a predominance of hyperphosphorylated RB, an absence of DNA-damage 
checkpoint in G1, non cell-cycle dependent expression of cyclin E, and lack of dependency on 
persistent serum stimulation and active MEK signaling during cell-cycle progression. 
Using the BrdUrd cumulative labelling technique, we estimated that the total cell-
cycle duration of ORMES-1 cells was 20 hours. This technique, when applied to 
heterogeneous cell populations cycling at different rates, returns predominantly the cell-cycle 
duration of the slowest cycling cells [20]. Time-lapse videomicroscopy was therefore used to 
provide the range of the cell-cycle duration values of individual ORMES-1 cells. This 
revealed that the population of ORMES-1 cells is heterogeneous with cells progressing 
through a complete cell-cycle in a time-window ranging from 12 to 21 hrs. The reason why 
ORMES-1 cells are heterogeneous in their cell-cycle duration is unclear. It is unlikely to 
result from mutations which would heritably influence the cell-cycle duration since careful 
examination of the cell-cycle durations of mother and daughter cells failed to reveal any 
positive correlation (data not shown). Interestingly, examination of the position of eGFP-
expressing mother and daughter cells revealed extensive movements within the colony. These 
movements are likely to modify the microenvironment such as the accessibility of ES cells to 
extracellular matrix-associated cytokines provided by feeder cells. This could result in 
randomly influencing the cell-cycle duration of individual ES cells.  
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The most striking feature of the murine ES cell cycle, apart from it being unusually 
rapid, is a short G1 phase which represents approximately 15% of the total cell-cycle 
duration, or 2 hrs. The duration of the G1 phase of mouse ES cells was calculated by 
measuring the delay between release from mitotic block and onset of [3H]-thymidine 
incorporation in synchronized cells [7]. Conditions for propagating primate ES cells 
precluded large-scale amplification which would be necessary to synchronize them by mitotic 
block. Therefore, we used an indirect method based on the combination of cumulative BrdUrd 
labelling and PLM to calculate the durations of the individual phases of the cell-cycle in 
asynchronously growing cell populations. Despite monkey ES cells having a total cell-cycle 
duration up to twice as long as that of mouse ES cells, the relative duration of the G1 phase is 
similar in the two species. In both species, the hyperphosphorylated form of pRB is 
predominent [7], further indicating that the vast majority of the cells are in the S and the 
G2/M phases of the cell-cycle. Taken together, these results indicate that a short G1-phase 
duration might be a common, and possibly universal, characteristic of ES cells, reflecting 
unique mechanisms of cell-cycle control which have been conserved throughout vertebrate 
evolution. Cells of the embryonal carcinoma (EC) stem cell line P19 also display a unusually 
short G1 phase [30]. Pluripotent EC stem cells that can be induced to differentiate into 
mesodermal derivatives following treatment with retinoic acid (RA). Interestingly, upon 
synchronization by exposure to the reversible mitotic blocker, P19 EC cells were particularly 
vulnerable to RA while they progressed from mitosis to the next S-phase and, by contrast, 
became resistant to RA-induced differentiation when they reached S-phase [30]. These 
observations suggest that the G1 phase corresponds to a window of increased sensitivity to 
differentiation signals. It is thus tempting to speculate that shortening of G1 phase might 
shield pluripotent cells from activities that induce differentiation [22]. 
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Which mechanism, therefore, underlies the rapid transit through the G1 phase in 
monkey ES cells ? In mouse ES cells, there is compelling evidence that the G1  S transition 
is not dependent on a functional cyclin D:Cdk4/6  RB:E2F pathway [1-5] and that rapid 
progression through the cell-cycle largely, if not exclusively, relies on constitutively active 
cyclin E:Cdk2 and cyclin A:Cdk2 complexes [6]. Monkey ES cells also express cyclin E 
during all phases of the cell-cycle suggesting that ectopic cyclin E-Cdk2 kinase activity may 
also be a characteristic feature of primate ES cells. Interestingly, ORMES-1 cells did not 
express cyclin A in all phases of their cell-cycle, as opposed to mouse ES cells [6]. Thus, 
mouse and monkey ES cells are likely to differ on the basis of the cell-cycle dependent 
regulation of cyclin A. The heterogenous cell-cycle duration that characterizes rhesus ES cells 
could result from discontinuous expression of cyclin A in a subset, or in all, Oct4+ cells. 
Mouse ES cells fail to undergo cell-cycle arrest in the G1 phase in response to DNA 
damage [13]. Both mechanisms involved in DNA-damage-dependent cell-cycle arrest – the 
chk1/chk2 kinase-dependent degradation of the Cdc25A phosphatase [27] and the activation 
of the p53-p21 axis [31] – are not functional in mouse ES cells [14]. Here, we show that 
rhesus monkey ES cells are similarly impaired in their ability to respond to growth-arrest in 
G1 after treatment with ionizing radiation. Then the question arises as to how these cells 
maintain genomic integrity in the absence of a G1 checkpoint. Following DNA-damage both 
mouse and rhesus ES cells undergo apoptosis ([13] and our unpublished data), suggesting that 
the function of p53 in ES cells is to trigger apoptosis in order to efficiently eliminate cells 
with damaged DNA. An alternative mechanism was recently suggested in mouse ES cells 
where, following DNA damage, transcriptionally active p53 repressed the activity of the 
nanog promoter and irreversibly induced differentiation, thus eliminating DNA-damaged cells 
from  the pool of undifferentiated stem cells [32]. Whether a similar mechanism operates in 
primate ES cells remains to be determined. 
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We show that rhesus monkey ES cells, like their murine counterpart [8, 10], do not 
rely on persistent serum stimulation for cell-cycle progression. Noteworthy, serum was 
withdrawn for 24 hours, thus allowing all cells to progress through any serum-dependent 
checkpoint, regardless of their position in the cell-cycle at the onset of serum withdrawal. 
These data indicate that rhesus monkey ES cells can efficiently progress through the G1 to S 
phase transition in the absence of mitogenic signals. Rhesus monkey ES cells also appear not 
sensitive to pharmacological inhibition of MEK, a property shared with mouse ES cells [10, 
33, 34]. In the mouse, inhibition of MEK-dependent signalling facilitates self-renewal [33] by 
sustaining expression of the expression of Oct-4 [34]. It remains to be determined whether a 
similar mechanism operates in primate ES cells. 
 
 
CONCLUSIONS 
 
To conclude, our results show that rhesus monkey ES cells share several fundamental 
properties of the cell cycle with mouse ES cells. We propose that these unique properties, that 
are distinct from that of other mammalian non-transformed cell types, are fundamental 
characteristics of embryonic stem cells. In view of the present results, together with several 
reports pointing to common mechanisms in cell-cycle regulation of mouse ES cells and other 
pluripotent cell types such as the pluripotent cells of the mouse epiblast [35], the epiblast-like 
(EPL) cells [6], the P19 EC cells [36,37], and the embryonic germ (EG) cells [38], we 
hypothetize that these unique cell cycle characteristics of ES cells may contribute to stemness. 
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LEGENDS 
 
Figure 1 : Population doubling time and expression of Oct-4 and Ki67 markers in ORMES-1 
cells. ORMES cells were plated on inactivated MEF at a density of 0.3 x 105 cells per cm2. 
(A) Cell numbers were counted at each time point (2 to 3 replicates) in two independent 
experiments using a Trypan blue exclusion assay. Means and standard errors to the mean 
(SEM) are indicated on the graph. (B) Immunohistofluorescent detection of Oct-4 (revealed 
by Cy3) in undifferentiated ORMES-1 cells between day 1 and day 6 of culture. Curve 
represents the mean percentages of Oct-4+ cells within colonies (n = 7 to 14) of ORMES-1 
cells. (C) Immunohistofluorescent detection of Oct-4 (revealed by Cy3) in ORMES-1 cells at 
day 2, 4 and 6 of the culture (D) Immunohistofluorescent detection of Oct-4 (revealed by 
Cy2) and Ki-67 (revealed by phycoerythrine) in ORMES-1 cells at day 3 of the culture. (C,D) 
Bar = 10 µM. 
 
Figure 2 : Cell-cycle duration of individual ORMES-1 cells measured by time lapse 
videomicroscopy two passages after infection with lentiviral vector expressing eGFP. 
Histogram represents the duration of 32 individual cell divisions over a time period of 48 hrs.  
 
Figure 3 : Cell-cycle distribution of ORMES-1 cells as measured by flow cytometry. 
ORMES-1 cells were grown in the presence of 50 µM BrdUrd for 24 hrs to label all 
proliferating cells. Cells were then processed for detection of BrdUrd incorporation and 
analysis of DNA content. (A) Dot plot representation of DNA/BrdUrd biparametric analysis 
for ORMES-1 and inactivated MEF. DNA was stained with propidium iodide (PI) (x-axis) 
and BrdUrd (y-axis) was revealed with FITC-conjugated anti-BrdUrd. (B) Histogram 
representation of the cell-cycle distribution of ORMES-1 cells gated as the BrdUrd+ cell 
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population (gate R1). (C) Histogram representation of the cell-cycle distribution of ORMES-1 
after differentiation induced by withdrawal of MEF and culture on gelatine-coated dishes for 
1 week. (B,C) Histograms show one representative experiment. Values are means and SEM 
calculated from three independent replicates. Frequencies of cells in each phase of the cell-
cycle were calculated using MODFIT software. 
 
Figure 4 : Duration of individual phases of the ORMES-1 and ORMES-6 cell-cycle by means 
of cumulative BrdUrd incorporation and Percentage of Labelled Mitosis (PLM) techniques. 
(A) Determination of Tc (length of the total cell-cycle), Ts (length of the S-phase) and 
TG1+G2+M (length of the G1+G2+M phases) by cumulative BrdUrd incorporation. ORMES-1 
and ORMES-6 cells were plated at a density of 0.3 x 105 cells per cm2. Three days after 
plating, cells were refed with fresh medium containing 50 µM BrdUrd, further cultured for 1 
to 10 hours, then processed at regular time intervals for dual detection of Oct-4 expression 
and BrdUrd incorporation. The four curves correspond to the percentages of BrdUrd+/Oct4+ 
cells (labelling indices, LI) calculated in four independent experiments [three experiments 
carried on ORMES-1 (red, green and blue curves), and one experiment carried out on 
ORMES-6 (black curve)]. For each curve, values are means and SEM calculated from 3 
replicates (replicates are sister coverslips from which individual LI are calculated). Projection 
of the extrapolated 100% LI value on the x-axis returns the duration of G1+G2+M phases 
(TG1+G2+M). Projection on the negative limb of the axis returns the duration of the S-phase 
(TS). (B) Determination of TG2/M (length of G2/M) by the PLM technique. ORMES-1 and 
ORMES-6 cells were plated at a density of 0.3 x 105 cells per cm2. Three days after plating, 
cells were exposed to 50 µM BrdUrd for 1 hr and further cultured for 1 to 10 hrs in BrdU-free 
medium. At regular time intervals, cells were processed for dual detection of Oct-4 expression 
and BrdUrd incorporation. The curves indicates the percentages of BrdUrd+/Oct4+ mitosis in 
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four independent experiments [three experiments on ORMES-1 (red, green and blue curves), 
and one experiment on ORMES-6 (black curve)]. For each curve, values are means and SEM 
calculated from 2-3 replicates (replicates are sister coverslips from which individual 
percentages are calculated). Projection of the extrapolated 100% value on the x-axis returns 
the duration of (TG2+M). The G1 duration has been calculated by substraction of TG2+M from 
TG1+G2/M using values obtained from sister cultures, which values are indicated in the same 
color code (i.e. the red curves in A and in B come from sister cultures). 
 
Figure 5 : DNA damage checkpoints in ORMES-1 cells. ORMES-1 cells were plated at a 
density of 0.3 x 105 cells per cm2 on MEF. Three days after plating, cells were irradiated (6 
Gy) and further cultured for 3 to 18 hrs before being processed for analysis of DNA content 
by flow cytometry. (A) Cell-cycle distributions of irradiated ORMES-1 cells as measured 0 to 
24 hrs after irradiation. (B) Percentages of ORMES-1 cells in G1, S and G2/M phases of the 
cell-cycle as a function of time following irradiation (means and SEM were calculated from 
three independent experiments). Percentages were calculated using MODFIT software. 
 
Figure 6 : Expression of cyclin E, cyclin A, and pRB in ORMES-1 cells. (A) Western blot 
analysis of the steady-state levels of cyclin E and cyclin A in undifferentiated ORMES-1 cells 
(1) and in their differentiated derivatives (2). Differentiation was achieved by plating 
ORMES-1 cells at high density on feeder-free, gelatin-coated culture dishes for 5 days, with 
reduced serum (5%). (B) Percentages of cyclin E and cyclin A positive cells in Oct-4+ ES 
cells and Oct-4- ES-derived cells calculated after immunohistofluorescence. 2 coverslips were 
examined for both cyclin E and cyclin A expression. The percentage of cyclin E+ cells was 
estimated on 590 Oct-4+ cells and 848 Oct-4- cells. A total of 580 Oct-4+ cells and 1123 Oct-
4- cells were counted to determine the percentage of cells expressing cyclin A expression. *** 
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: p < 0.001 (Student T-test). (C) Immunohistofluorescent detection of Oct-4 (revealed by Cy2) 
and cyclin E (revealed by Cy3) in undifferentiated ORMES-1 cells (panel 1) or in 
differentiated ORMES-1 cells (panel 2). (D) Immunohistofluorescent detection of Oct-4 
(revealed by Cy2) and cyclin A (revealed by Cy3) in undifferentiated ORMES-1 cells (panel 
1) or in differentiated ORMES-1 cells (panel 2). Western blot analysis of pRB expression in 
undifferentiated ORMES-1 ES cells (1), in embryonic fibroblasts (2). p105 and p110 indicate 
molecular weights of hypophosphorylated and hyperphosphorylated pRB, respectively. (C,D) 
Bar = 10 µM. 
 
Figure 7 : Dependency on serum stimulation and MEK signaling of ORMES-1 cells. 
ORMES-1 cells were plated at a density of 0.3 x 105 cells per cm2. (A-D) Two days after 
plating, cells were refed with fresh medium lacking serum, or containing the MEK inhibitors 
PD98059 (PD98) or U0126, or vehicle (DMSO) alone, and further cultured for 24 hrs. Cells 
were then processed for DNA analysis by flow cytometry. Percentages of cells in each phase 
of the cell-cycle were calculated using MODFIT software. (A) Cell-cycle distribution of 
ORMES-1 cells cultured in the presence (+ FBS) or in the absence (-FBS) of serum (one 
representative expriment). Distributions are compared by means of X2 test. (B) Histograms 
showing the percentages of ORMES-1 cells in G1, S and G2/M phases (+/- FBS). Means and 
SEM were calculated from three independent experiments and compared by means of Student 
T-test. ns, non significant. (C) Cell-cycle distribution of ORMES-1 cells cultured in the 
presence of 25 µM PD98059, or 10 µM U0126, or in vehicle alone (one representative 
experiment). Distributions are compared by means of X2 test. (D) Histograms showing the 
percentages of ORMES-1 cells in G1, S and G2/M phases (+/- MEK inhibitors). Means and 
SEM were calculated from three independent experiments and compared by means of Student 
T-test. ns, non significant. (E) ORMES-1 cells were propagated in the presence of PD98059 
H
AL author m
anuscript    inserm
-00132737, version 2
 24 
(dotted line), or in vehicle alone (plain line), for 7 days. Cell numbers were counted at the 
indicated time points using a Trypan blue exclusion assay. Means and SEM were calculated 
from two replicates. 
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